179 related articles for article (PubMed ID: 36428999)
1. The Role of the Immune Phenotype in Tumor Progression and Prognosis of Patients with Mycosis Fungoides: A Quantitative Immunohistology Whole Slide Approach.
Aulasevich N; Haist M; Försch S; Weidenthaler-Barth B; Mailänder V
Cells; 2022 Nov; 11(22):. PubMed ID: 36428999
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
4. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
6. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
10. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
11. Transformation of mycosis fungoides: T-cell receptor beta gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma.
Wood GS; Bahler DW; Hoppe RT; Warnke RA; Sklar JL; Levy R
J Invest Dermatol; 1993 Sep; 101(3):296-300. PubMed ID: 8396607
[TBL] [Abstract][Full Text] [Related]
12. Correlations between clinical and pathological features in 17 cases of mycosis fungoides before and after transformation.
Bittencourt AL; Oliveira PD; Carvalho-Andrade A; Araújo I
Int J Dermatol; 2015 Sep; 54(9):e327-31. PubMed ID: 26147565
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
14. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
Vergier B; de Muret A; Beylot-Barry M; Vaillant L; Ekouevi D; Chene G; Carlotti A; Franck N; Dechelotte P; Souteyrand P; Courville P; Joly P; Delaunay M; Bagot M; Grange F; Fraitag S; Bosq J; Petrella T; Durlach A; De Mascarel A; Merlio JP; Wechsler J
Blood; 2000 Apr; 95(7):2212-8. PubMed ID: 10733487
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients.
Wechsler J; Ingen-Housz-Oro S; Deschamps L; Brunet-Possenti F; Deschamps J; Delfau MH; Calderaro J; Ortonne N
Pathology; 2022 Oct; 54(6):729-737. PubMed ID: 35577607
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
[TBL] [Abstract][Full Text] [Related]
18. Transformed Mycosis Fungoides with a Cytotoxic T-Cell Phenotype.
Hiraiwa S; Hashimoto N; Ueda T; Sugiyama T; Yokoyama K; Matsuyama T; Tajiri T; Nakamura N
Int J Surg Pathol; 2022 Oct; 30(7):816-822. PubMed ID: 35253522
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
20. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
